The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey
Abstract
Share and Cite
Mısırcı, S.; Ekin, A.; Yağız, B.; Coşkun, B.N.; Dalkılıç, E.; Pehlivan, Y. The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey. Diagnostics 2024, 14, 2205. https://doi.org/10.3390/diagnostics14192205
Mısırcı S, Ekin A, Yağız B, Coşkun BN, Dalkılıç E, Pehlivan Y. The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey. Diagnostics. 2024; 14(19):2205. https://doi.org/10.3390/diagnostics14192205
Chicago/Turabian StyleMısırcı, Salim, Ali Ekin, Burcu Yağız, Belkıs Nihan Coşkun, Ediz Dalkılıç, and Yavuz Pehlivan. 2024. "The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey" Diagnostics 14, no. 19: 2205. https://doi.org/10.3390/diagnostics14192205